![]() |
|
|
Vol. 288, Issue 2, 446-454, February 1999
Clinical Pharmacology and Gerontology Research Unit, Department of
Veterans Affairs Medical Center, Boise, Idaho (B.M., R.V.M., J.L.,
R.D.O., R.E.V.);
Mountain States Medical Research Institute, Boise,
Idaho (R.V.M., J.L., R.D.O., R.E.V.); and
Department of Medicine and
Pharmacology, University of Washington School of Medicine, Seattle,
Washington (R.D.O., R.E.V.)
The 2-amino-3-benzoylthiophene PD 81,723 has been shown to exhibit
allosteric enhancement of adenosine A1 receptor binding and
function. The aim of this study was to clarify the mechanism of this
effect using membranes purified from rat brain and Chinese hamster
ovary (CHO)-A1 cells that stably express the rat adenosine A1 receptor as well as intact CHO-A1 and
nontransfected CHO cells. In membranes containing 100 µM magnesium,
(2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone (PD 81,723) significantly increased the affinity of the adenosine A1 receptor agonist, cyclopentyladenosine, for the
low-affinity receptor without affecting high-affinity binding or
Bmax. In intact cells, PD 81,723 inhibited
basal adenylyl cyclase (AC) activity as well as forskolin-, cholera
toxin-, and pertussis toxin-stimulated AC activity in
CHO-A1 and CHO cells. Basal AC activity was inhibited 49%
in CHO and 82% in CHO-A1 cells by 30 µM PD 81,723. In
CHO-A1 cells, half-maximal inhibition of
forskolin-stimulated AC occurred at 5 µM PD 81,723 compared to 10 µM in CHO cells. Cholera toxin-stimulated AC was reduced 90% in both
CHO and CHO-A1 cells by 30 µM PD 81,723. At the same
concentration of PD 81,723, pertussis toxin-stimulated AC activity was
reduced 86% (CHO-A1) and 77% (CHO).
[3H]forskolin was displaced from purified rat liver AC by
PD 81,723 with an IC50 of 96 µM. These results
demonstrate that two mechanisms appear to contribute to the observed
effects of PD 81,723. One mechanism is allosteric enhancement of
adenosine A1 receptor function. Results from transfected
and nontransfected cells suggest that PD 81,723 also inhibits AC
directly by binding to the catalytic unit at or near the
forskolin-binding site.
This article has been cited by other articles:
![]() |
H. Figler, R. A. Olsson, and J. Linden Allosteric Enhancers of A1 Adenosine Receptors Increase Receptor-G Protein Coupling and Counteract Guanine Nucleotide Effects on Agonist Binding Mol. Pharmacol., December 1, 2003; 64(6): 1557 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Swaminath, T. W. Lee, and B. Kobilka Identification of an Allosteric Binding Site for Zn2+ on the beta 2 Adrenergic Receptor J. Biol. Chem., January 3, 2003; 278(1): 352 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Swaminath, J. Steenhuis, B. Kobilka, and T. W. Lee Allosteric Modulation of beta 2-Adrenergic Receptor by Zn2+ Mol. Pharmacol., January 1, 2002; 61(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Knoflach, V. Mutel, S. Jolidon, J. N. C. Kew, P. Malherbe, E. Vieira, J. Wichmann, and J. A. Kemp Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site PNAS, October 16, 2001; (2001) 231358298. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Leppik and N. J. M. Birdsall Agonist Binding and Function at the Human alpha 2A-Adrenoceptor: Allosteric Modulation by Amilorides Mol. Pharmacol., November 1, 2000; 58(5): 1091 - 1099. [Abstract] [Full Text] |
||||
![]() |
F. Knoflach, V. Mutel, S. Jolidon, J. N. C. Kew, P. Malherbe, E. Vieira, J. Wichmann, and J. A. Kemp Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site PNAS, November 6, 2001; 98(23): 13402 - 13407. [Abstract] [Full Text] [PDF] |
||||